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TO THE EDITOR
Proteases of the A disintegrin and metal-
loproteinase (ADAM) family form a
large group of metalloenzymes that
function primarily to cleave (or shed)
extracellular domains from plasma
membrane–bound signaling molecules.
Although ADAM proteases are not
thought to have strict cleavage-site spe-
cificities, ADAM17 and ADAM10 have
evolved distinct substrate preferences,
despite being the most closely related
members of the family. ADAM17 is the
principal sheddase of TNF-a and the
majority of the EGFR ligands (Peschon
et al., 1998; Blobel, 2005), whereas
ADAM10 is required for Notch and
amyloid precursor protein shedding
(van Tetering et al., 2009; Kuhn et al.,
2010). The physiological importance of
ADAM17 in EGFR signaling is based
on the striking phenotypic similarities
between Adam17 / and Egfr /
mutant mice. Both die at birth due to
multiple developmental defects invol-
ving the heart, lung, and the skin
(Miettinen et al., 1995; Peschon et al.,
1998; Blobel, 2005).
Notch receptors are conserved mem-
brane-anchored transcription regulators
activated by proteolysis (Kopan and
Ilagan, 2009; van Tetering and Vooijs,
2011). During maturation in the Golgi,
Notch receptors are cleaved by furin-like
convertases at site 1 (S1) located in a loop
protruding from the negative regulatory
region. When denatured for western blot
analysis, the membrane-bound form of
Notch1 (transmembrane intracellular
fragment) migrates at B120 kDa. Ligand
binding unfolds the Lin12-Notch repeat
module to expose and allow cleavage at
Val1711 (‘S2’) creating ‘notch extracel-
lular truncation’, which is 55 amino acids
shorter than transmembrane intracellular
fragment. S2 cleavage is followed by
g-secretase cleavage at Val1744 (‘S3’),
releasing the B110 kDa Notch intracel-
lular domain (NICD) that acts as a trans-
criptional regulator (Supplementary
Figure S1 online). In all metazoan,
the essential role of ADAM10 and its
orthologs (Kuzbanian and Sup-17) in
executing the Notch S2 cleavage is
evident by the phenotypic similarities
between the Notch and Adam10/Kuz/
Sup-17 mutants in mice, flies, and
worms, respectively (van Tetering and
Vooijs, 2011).
ADAM17 can mediate S2 cleavage
under special, nonphysiological circum-
stances. It cleaves T-ALL-associated
mutant forms of Notch that are ligand
independent in tissue culture cells
(Bozkulak and Weinmaster, 2009). It
also cleaves Notch proteins unfolded
in vitro with Ca2þ chelators (Rand
et al., 2000); however, a physiological
activity for ADAM17 in S2 cleavage
should be ruled out for two reasons.
First, most Adam10 loss-of-function
phenotypes examined to date (including
skin phenotypes) phenocopied Notch
loss (Demehri et al., 2008; Dumortier
et al., 2010; Weber et al., 2011),
indicating that ADAM17 cannot
rescue S2 cleavage in Adam10-deficient
tissues. Second, in cell-based assays,
ligand-induced Notch signaling depends
on ADAM10 (Bozkulak and Weinmaster,
2009; van Tetering et al., 2009) and
occurs at Val1711 S2 cleavage site
during ligand-dependent Notch1 signa-
ling (van Tetering et al., 2009).
Recently, Murthy et al. (2012) sugges-
ted a role for ADAM17 in maintaining a
baseline level of Notch1 activity (‘tonic’
Notch signal) in epidermal keratinocytes
in a ligand-independent manner. We
examined the data supporting this
function in the same genetic model
used by Murthy et al. (2012), arriving
at different conclusions. Both Murthy
et al. (2012) and Franzke et al. (2012)
characterized the same keratinocyte-
specific Adam17-knockout mouse
model (Krt14-A17DKC) and observed
altered epidermal differentiation and
the onset of chronic dermatitis and
severe myeloproliferative disease.
Although both studies concur that
ADAM10 is required for ligand-
dependent Notch signaling during skin
development, Murthy et al. concluded
that Adam17 loss alleviated a Notch-
dependent suppression of proinflam-
matory cytokine thymic stromal
lymphopoietin (TSLP). According to
Murthy et al., ADAM17 maintains a
ligand-independent (‘tonic’) mode of
Notch signaling in skin, which in turn
suppressed TSLP production. Measure-
ments of TSLP by ELISA demonstrate
that g-secretase-deficient keratinocytes
produced indistinguishable amounts
of TSLP from the wild-type cells
(Demehri et al., 2008); however, this
finding is inconsistent with the idea that
a ‘tonic’ Notch signal regulates TSLP
in skin.
We have provided an alternative
explanation by showing that the loss
of ADAM17-dependent EGFR signaling
impaired the maintenance of epidermal
differentiation and barrier integrity in
Krt14-A17DKC mice (Franzke et al.,
2012), which would be sufficient for
TSLP induction as demonstrated in
several animal models with epidermal
barrier defects, including Gata3 /
(de Guzman Strong et al., 2006),
epidermis-specific loss of Notch
(Demehri et al., 2008), or mice
lacking the lipid transporter FATP4
(Demehri et al., 2008). Mice with a
persistent defect in epidermal barrier
maintenance have chronically elevated
levels of TSLP and G-CSF expression,
which together with additional
cytokines drive leukocyte infiltration
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and promote development of atopic
dermatitis, myeloproliferative disease,
and asthma. Because this TSLP
production also occurs in mice with a
competent Notch signaling system but a
defective epidermal differentiation
program, TSLP expression is triggered
by a mechanism that does not involve a
cell-autonomous Notch function
(Demehri et al., 2008).
In addition to the genetic and cell-
based data summarized above, both the
methods and the interpretation of the
data, which supported a physiological
role for ADAM17 in ‘tonic’ Notch sig-
naling, raise several concerns. To sup-
port the conclusion that ADAM17
regulates ligand-independent Notch sig-
naling, Murthy et al. activated Notch
with EDTA, an in vitro assay with no
physiological correlate rendering Notch
permissive to cleavage by either
ADAM10 or ADAM17. To provide phy-
siological evidence, they presented data
suggesting that NICD amounts were
reduced in Krt14-A17DKC epidermis
in vivo at postnatal day 56 (P56) versus
control mice. A 72-kDa band labeled as
NICD (Val1744) is greatly diminished in
Adam17-deficient epidermis (Murthy
et al., 2012). On the basis of the
molecular weight of an intact NICD
(B110 kDa in SDS-PAGE), this
fragment is most likely a metabolic
product of NICD that retained the
VLLS epitope but lost a fraction of its
C-terminus. As ADAM10 is present, it
was unclear to us why the loss of ‘tonic’
signal will cause such a pronounced
change in NICD levels.
To evaluate the contribution of
ADAM17 to NICD production in vivo,
we repeated this experiment using epi-
dermal lysates from the same Krt14-
A17DKC mice (named Adam17Dep in
Murthy et al. (2012)) and analyzed
these at the same and more stages for
Notch proteolysis. Because of the small
differences in molecular weight
between notch extracellular truncation
and NICD (33 amino-acid residues), we
visualized NICD with cleavage-specific
antibodies (Figure 1a). We analyzed the
epidermises from newborn, P10, and
P56 Krt14-A17DKC mice using an anti-
body recognizing the C-terminus to
identify total Notch1 (transmembrane
intracellular fragment) and a Val1744
neoepitope antibody to detect NICD
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Figure 1. Keratinocyte-derived ADAM17 is dispensable for Notch1 activation, and the upregulation of the epidermal alarmin TSLP in Krt14-A17DKC mice
depends on skin barrier defects. (a) Western blot analysis of epidermal lysates for activated S3-cleaved NOTCH1; NICD (Val1744, upper panels) in Krt14-A17DKC
and Krt14-EgfrDKC mice revealed no differences to their littermate controls at different postnatal ages, whereas NICD was completely lost in the epidermis of Krt14-
A10DKC animals. NOTCH1 protein (TMIC, middle panel) and Lamin A/C (Ctrl, bottom panels) were used as loading controls. Data from each postnatal age are
representative of at least three mice (for each genotype). (b) Quantitative Tslp gene-expression analysis of Krt14-A17DKC or Krt14-EgfrDKC skin revealed no changes
in the expression on P10, but significantly elevated expression at P19 and P56, when the skin barrier defects are prominent. Mice analyzed for Krt14-A17DKC and
controls: P10, n¼5; P19, n¼ 5; P56, n¼ 4; and for Krt14-EgfrDKC and control littermates: n¼ 3 for all postnatal ages. (c) Analysis of serum TSLP levels of Krt14-
A17DKC or Krt14-EgfrDKC animals at P10, P19, and P56 revealed increased TSLP levels due to severe skin barrier defects starting at P19. The data derived from three
different mice for each genotype. Data in b and c are shown as mean±SEM; *Po0.05; **Po0.01. TMIC, transmembrane intracellular fragment.
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expected, NICD production in Krt14-
A17DKC, Krt14-EgfrDKC, and control epi-
dermises is indistinguishable in all post-
natal ages, consistent with an intact,
ADAM10-dependent, canonical signal-
ing pathway. In contrast, NICD produc-
tion in the Krt14-A10DKC (named
Adam10epi / in Weber et al. (2011))
epidermis at P1 was impaired, indicat-
ing that ADAM10 is the sheddase of
Notch1 in the epidermis (Figure 1a)
(Weber et al., 2011).
If ‘tonic’ Notch signaling exists, the
loss of tonic signals predicts that ele-
vated TSLP production (released from
Notch-mediated inhibition) should pre-
cede (perhaps even drive) the defects in
epidermal differentiation and barrier
integrity, as seen in Notch- and Fatp4-
deficient animals (Demehri et al., 2008).
Conversely, if EGFR deficiency caused
barrier defects that then trigger Tslp
expression, TSLP levels should rise
only after the barrier defects are mani-
fested. In order to analyze the time
course of keratinocyte-derived TSLP
production in Krt14-A17DKC animals,
we measured the Tslp mRNA in P10,
P19, and P56 skin. Importantly, Tslp
mRNA expression in P10 skin is
identical to controls. Only when prono-
unced differentiation and barrier defects
were noted (P19) (Franzke et al., 2012)
did Tslp mRNA accumulate, and
remained consistently elevated in the
skin of 2-month-old animals (Figure 1b).
Accordingly, TSLP serum levels were
significantly elevated in P19 and P56
animals, but remained unchanged com-
pared with controls in P10 preceding
barrier dysfunction (Figure 1c). In addi-
tion, we have seen the same time course
for an increase in TSLP in Krt14-EgfrDKC
mice (Figures 1b and c). These results
argue against a cell intrinsic upregula-
tion of keratinocyte Tslp through the loss
of Notch-dependent suppression and
support the null hypothesis that TSLP
production follows barrier disruption
(Demehri et al., 2008).
As Adam17 disruption in these studies
is achieved using the identical Krt14-
A17DKC animal model, and as deletion
of Adam17 in keratinocytes did not lead
to elevation of Tslp mRNA until after a
barrier defect was detected, Adam17
loss was unlikely to be associated with
reduced epidermal Notch signaling
in vivo. All the data can be explained
by strongly diminished activation of
EGFR in the epidermis of Krt14-A17DKC
mice caused by reduced ADAM17-
dependent EGFR-ligand shedding,
which led to the reduced expression of
transglutaminases, reducing the cross-
linking of barrier proteins and thereby
causing a differentiation and skin
barrier defect (Franzke et al., 2012).
Although it is possible that ADAM17
may cleave Notch proteins in vivo
under some yet-to-be-described circum-
stances, the data and analysis provided
herein do not support the ‘tonic’ Notch
signaling, inhibiting TSLP hypothesis.
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